The effect of resveratrol on blood pressure in a rat model of preeclampsia

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 25, Issue 6, 2012, Pages 845-848

  Moraloglu, Ozlem ^a   Engin Ustun, Yaprak ^a   Tonguç, Esra ^a   Var, Turgut ^a   Tapisiz, Ömer Lütfü ^a   Ergün, Hakan ^b   Guvenc, Tolga ^c   Gacar, Ayhan ^c  

^a Department of Perinatology   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

^c ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

Preeclampsia; Rat; Resveratrol

Indexed keywords

CREATININE; DEOXYCORTICOSTERONE ACETATE; RESVERATROL;

ANIMAL EUTHANASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD FLOW; BLOOD PRESSURE; BLOOD PRESSURE CUFF; BRAIN TISSUE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FETUS; GESTATIONAL AGE; HYPERTENSION; KIDNEY; KIDNEY BLOOD FLOW; LASER DOPPLER FLOWMETRY; MEAN ARTERIAL PRESSURE; MICROSCOPY; NONHUMAN; PARIETAL LOBE; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL; RAT; SYSTOLIC BLOOD PRESSURE; TREATMENT RESPONSE; URINALYSIS;

ANIMALS; ANTIHYPERTENSIVE AGENTS; ANTIOXIDANTS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; DOWN-REGULATION; DRUG EVALUATION, PRECLINICAL; FEMALE; MALE; PRE-ECLAMPSIA; PREGNANCY; RATS; RATS, WISTAR; RENAL CIRCULATION; STILBENES;

EID: 84861063830     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2011.599081     Document Type: Article

References (18)

1. LaMarca BD, Gilbert J, Granger JP. Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia. Hypertension 2008;51:982-988.
2. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005;365: 785-799.
3. Mitchell BM, Cook LG, Danchuk S, Puschett JB. Uncoupled endothelial nitric oxide synthase and oxidative stress in a rat model of pregnancyinduced hypertension. Am J Hypertens 2007;20:1297-1304.
4. Ianosi-Irimie M, Vu HV, Whitbred JM, Pridjian CA, Nadig JD, Williams MY, Wrenn DC, et al. A rat model of preeclampsia. Clin Exp Hypertens 2005;27:605-617.
5. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, et al. Resveratrol improves health and survival of mice on a highcalorie diet. Nature 2006;444:337-342.
6. Kroon PA, Iyer A, Chunduri P, Chan V, Brown L. The cardiovascular nutrapharmacology of resveratrol: Pharmacokinetics, molecular mechanisms and therapeutic potential. Curr Med Chem 2010;17:2442-2455.
7. Rivera L, Morón R, Zarzuelo A, Galisteo M. Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. Biochem Pharmacol 2009;77: 1053-1063.
8. Sener G, Topaloglu N, Sehirli AO, Ercan F, Gedik N. Resveratrol alleviates bleomycin-induced lung injury in rats. Pulm Pharmacol Ther 2007;20:642-649.
9. Csiszar A, Labinskyy N, Olson S, Pinto JT, Gupte S, Wu JM, Hu F, et al. Resveratrol prevents monocrotaline-induced pulmonary hypertension in rats. Hypertension 2009;54:668-675.
10. Nash P, Wentzel P, Lindeberg S, Naessén T, Jansson L, Olovsson M, Eriksson UJ. Placental dysfunction in Suramin-treated rats-a new model for pre-eclampsia. Placenta 2005;26:410-418.
11. Alexander BT, Cockrell KL, Massey MB, Bennett WA, Granger JP. Tumor necrosis factor-alpha-induced hypertension in pregnant rats results in decreased renal neuronal nitric oxide synthase expression. Am J Hypertens 2002;15:170-175.
12. Tam Tam KB, Lamarca B, Arany M, Cockrell K, Fournier L, Murphy S, Martin JN Jr, Granger JP. Role of reactive oxygen species during hypertension in response to chronic antiangiogenic factor (sFlt-1) excess in pregnant rats. Am J Hypertens 2011;24:110-113.
13. Crews JK, Herrington JN, Granger JP, Khalil RA. Decreased endothelium-dependent vascular relaxation during reduction of uterine perfusion pressure in pregnant rat. Hypertension 2000;35:367-372.
14. Chan V, Fenning A, Iyer A, Hoey A, Brown L. Resveratrol improves cardiovascular function in DOCA-salt hypertensive rats. Curr Pharm Biotechnol 2011;12:429-436.
15. Toklu HZ, Sehirli O, Ersahin M, Süleymanoglu S, Yiginer O, Emekli-Alturfan E, Yarat A, et al. Resveratrol improves cardiovascular function and reduces oxidative organ damage in the renal, cardiovascular and cerebral tissues of two-kidney, one-clip hypertensive rats. J Pharm Pharmacol 2010;62:1784-1793.
16. Förstermann U. Oxidative stress in vascular disease: Causes, defense mechanisms and potential therapies. Nat Clin Pract Cardiovasc Med 2008;5:338-349.
17. Cao Z, Fang J, Xia C, Shi X, Jiang BH. trans-3,4,5'-Trihydroxystibene inhibits hypoxia-inducible factor 1 alpha and vascular endothelial growth factor expression in human ovarian cancer cells. Clin Cancer Res 2004;10:5253-5263.
18. Olas B, Wachowicz B. Resveratrol and vitamin C as antioxidants in blood platelets. Thromb Res 2002;106:143-148.